151 related articles for article (PubMed ID: 29762173)
21. Inhibitory Effect of Individual or Combinations of Broadly Neutralizing Antibodies and Antiviral Reagents against Cell-Free and Cell-to-Cell HIV-1 Transmission.
Gombos RB; Kolodkin-Gal D; Eslamizar L; Owuor JO; Mazzola E; Gonzalez AM; Korioth-Schmitz B; Gelman RS; Montefiori DC; Haynes BF; Schmitz JE
J Virol; 2015 Aug; 89(15):7813-28. PubMed ID: 25995259
[TBL] [Abstract][Full Text] [Related]
22. Incomplete Downregulation of CD4 Expression Affects HIV-1 Env Conformation and Antibody-Dependent Cellular Cytotoxicity Responses.
Prévost J; Richard J; Medjahed H; Alexander A; Jones J; Kappes JC; Ochsenbauer C; Finzi A
J Virol; 2018 Jul; 92(13):. PubMed ID: 29669829
[TBL] [Abstract][Full Text] [Related]
23. Short Communication: Small-Molecule CD4 Mimetics Sensitize HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity by Antibodies Elicited by Multiple Envelope Glycoprotein Immunogens in Nonhuman Primates.
Ding S; Verly MM; Princiotto A; Melillo B; Moody AM; Bradley T; Easterhoff D; Roger M; Hahn BH; Madani N; Smith AB; Haynes BF; Sodroski J; Finzi A
AIDS Res Hum Retroviruses; 2017 May; 33(5):428-431. PubMed ID: 27846736
[TBL] [Abstract][Full Text] [Related]
24. Blockage of CD59 Function Restores Activities of Neutralizing and Nonneutralizing Antibodies in Triggering Antibody-Dependent Complement-Mediated Lysis of HIV-1 Virions and Provirus-Activated Latently Infected Cells.
Yang K; Lan J; Shepherd N; Hu N; Xing Y; Byrd D; Amet T; Jewell C; Gupta S; Kounga C; Gao J; Yu Q
J Virol; 2015 Sep; 89(18):9393-406. PubMed ID: 26136568
[TBL] [Abstract][Full Text] [Related]
25. A novel assay for antibody-dependent cell-mediated cytotoxicity against HIV-1- or SIV-infected cells reveals incomplete overlap with antibodies measured by neutralization and binding assays.
Alpert MD; Heyer LN; Williams DE; Harvey JD; Greenough T; Allhorn M; Evans DT
J Virol; 2012 Nov; 86(22):12039-52. PubMed ID: 22933282
[TBL] [Abstract][Full Text] [Related]
26. Dual-Affinity Re-Targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cells.
Sung JA; Pickeral J; Liu L; Stanfield-Oakley SA; Lam CY; Garrido C; Pollara J; LaBranche C; Bonsignori M; Moody MA; Yang Y; Parks R; Archin N; Allard B; Kirchherr J; Kuruc JD; Gay CL; Cohen MS; Ochsenbauer C; Soderberg K; Liao HX; Montefiori D; Moore P; Johnson S; Koenig S; Haynes BF; Nordstrom JL; Margolis DM; Ferrari G
J Clin Invest; 2015 Nov; 125(11):4077-90. PubMed ID: 26413868
[TBL] [Abstract][Full Text] [Related]
27. Anti-HIV-1 antibody-dependent cellular cytotoxicity: is there more to antibodies than neutralization?
Lee WS; Kent SJ
Curr Opin HIV AIDS; 2018 Mar; 13(2):160-166. PubMed ID: 29194123
[TBL] [Abstract][Full Text] [Related]
28. Cross-Reactive Antibodies With the Capacity to Mediate HIV-1 Envelope Glycoprotein-Targeted Antibody-Dependent Cellular Cytotoxicity Identified in HIV-2-Infected Individuals.
Karlsson I; Tingstedt JL; Şahin GÖ; Hansen M; Szojka Z; Buggert M; Biague A; Da Silva Z; Månsson F; Esbjörnsson J; Norrgren H; Medstrand P; Fomsgaard A; Jansson M;
J Infect Dis; 2019 May; 219(11):1749-1754. PubMed ID: 30715363
[TBL] [Abstract][Full Text] [Related]
29. Nef Proteins from HIV-1 Elite Controllers Are Inefficient at Preventing Antibody-Dependent Cellular Cytotoxicity.
Alsahafi N; Ding S; Richard J; Markle T; Brassard N; Walker B; Lewis GK; Kaufmann DE; Brockman MA; Finzi A
J Virol; 2015 Dec; 90(6):2993-3002. PubMed ID: 26719277
[TBL] [Abstract][Full Text] [Related]
30. Humoral and Innate Antiviral Immunity as Tools to Clear Persistent HIV Infection.
Ferrari G; Pollara J; Tomaras GD; Haynes BF
J Infect Dis; 2017 Mar; 215(suppl_3):S152-S159. PubMed ID: 28520963
[TBL] [Abstract][Full Text] [Related]
31. Immunization with Clinical HIV-1 Env Proteins Induces Broad Antibody Dependent Cellular Cytotoxicity-Mediating Antibodies in a Rabbit Vaccination Model.
Karlsson I; Borggren M; Jensen SS; Heyndrickx L; Stewart-Jones G; Scarlatti G; Fomsgaard A
AIDS Res Hum Retroviruses; 2018 Feb; 34(2):206-217. PubMed ID: 28982260
[TBL] [Abstract][Full Text] [Related]
32. Harnessing Antibody-Dependent Cellular Cytotoxicity To Control HIV-1 Infection.
Abuharfeil NM; Yaseen MM; Alsheyab FM
ACS Infect Dis; 2019 Feb; 5(2):158-176. PubMed ID: 30525453
[TBL] [Abstract][Full Text] [Related]
33. Beyond Viral Neutralization.
Lewis GK; Pazgier M; Evans DT; Ferrari G; Bournazos S; Parsons MS; Bernard NF; Finzi A
AIDS Res Hum Retroviruses; 2017 Aug; 33(8):760-764. PubMed ID: 28084796
[TBL] [Abstract][Full Text] [Related]
34. IgA Targeting Human Immunodeficiency Virus-1 Envelope gp41 Triggers Antibody-Dependent Cellular Cytotoxicity Cross-Clade and Cooperates with gp41-Specific IgG to Increase Cell Lysis.
Duchemin M; Khamassi M; Xu L; Tudor D; Bomsel M
Front Immunol; 2018; 9():244. PubMed ID: 29651286
[TBL] [Abstract][Full Text] [Related]
35. Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity.
Mayr LM; Decoville T; Schmidt S; Laumond G; Klingler J; Ducloy C; Bahram S; Zolla-Pazner S; Moog C
Sci Rep; 2017 Oct; 7(1):12655. PubMed ID: 28978939
[TBL] [Abstract][Full Text] [Related]
36. Positive correlation between the natural killer and gp 120/41-specific antibody-dependent cellular cytotoxic effector functions in HIV-infected individuals.
Ahmad A; Menezes J
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct; 10(2):115-9. PubMed ID: 7552474
[TBL] [Abstract][Full Text] [Related]
37. Reduced Potency and Incomplete Neutralization of Broadly Neutralizing Antibodies against Cell-to-Cell Transmission of HIV-1 with Transmitted Founder Envs.
Li H; Zony C; Chen P; Chen BK
J Virol; 2017 May; 91(9):. PubMed ID: 28148796
[TBL] [Abstract][Full Text] [Related]
38. Enhancing natural killer cell function with gp41-targeting bispecific antibodies to combat HIV infection.
Ramadoss NS; Zhao NQ; Richardson BA; Grant PM; Kim PS; Blish CA
AIDS; 2020 Jul; 34(9):1313-1323. PubMed ID: 32287071
[TBL] [Abstract][Full Text] [Related]
39. Increased, Durable B-Cell and ADCC Responses Associated with T-Helper Cell Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site.
Bogers WMJM; Barnett SW; Oostermeijer H; Nieuwenhuis IG; Beenhakker N; Mortier D; Mooij P; Koopman G; Remarque E; Martin G; Lai RP; Dey AK; Sun Y; Burke B; Ferrari G; Montefiori D; Martin L; Davis D; Srivastava I; Heeney JL
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701402
[TBL] [Abstract][Full Text] [Related]
40. HIV-gp140-Specific Antibodies Generated From Indian Long-Term Non-Progressors Mediate Potent ADCC Activity and Effectively Lyse Reactivated HIV Reservoir.
Dhande JR; Bagul RD; Thakar MR
Front Immunol; 2022; 13():844610. PubMed ID: 35309295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
